VALENCIA, Calif. – June 7, 2024 – Nusano, Inc., a physics company transforming the production of medical...
Nusano Names D. Scott Holbrook as Chairman of its Board
read more
News
Nusano Expands Executive Management to Support Q1 2025 Radioisotope Commercialization
VALENCIA, Calif. – May 29, 2024 – Nusano, Inc., a physics company transforming the production of medical...
Nusano to Host Radiopharmaceuticals Educational Webinar
EVENT REPLAY NOW AVAILABLE Recorded June 28, 2024Nusano and LifeSci Advisors invite you to go back to school... Join...
Nusano to Present at Jefferies Radiopharma Innovation Summit
VALENCIA, Calif. – April 10, 2024 – Nusano, a physics company transforming the production of medical radioisotopes,...
Nusano to Present Isotope Production Capabilities and Commercialization Plans at 7th Theranostics World Congress
Nusano will present at the 7th Theranostics World Congress taking place March 22-24, 2024, in Santiago, Chile. Greg Moffitt, Nusano Director of Target Development, will provide an overview of the company’s proprietary radioisotope production platform on Sunday, March 24.
Nusano Opens Radiochemistry Laboratory to Advance Isotope Commercialization and Customer Collaboration
Photo above: On Friday, March 8, 2024, representatives from Nusano and The Wasatch Group cut the ribbon on the...
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates